“I am pleased with the progress we have made in light of the challenges we faced in the second half of 2005. During 2005, we improved our operations, introduced enhanced products and extended the value proposition we offer our customers. Our businesses are well positioned to grow as we facilitate improved revenue cycle management, the capturing and sharing of clinical information and the empowerment of the patient.”
“Due to a variety of recent factors, we expect to report stronger than anticipated first quarter results and with this in mind are increasing our full year expectations. We are completing our normal closing process and expect to provide more detail on May 4, 2006, our previously scheduled earnings release date.”
